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Abstract
Background: Several studies have linked low birth weight to adverse levels of cardiovascular risk
factors and related diseases. However, information is sparse at a community level in the U.S.
general population regarding the effects of low birth weight on the longitudinal trends in
cardiovascular risk factor variables measured concurrently from childhood to adolescence.
Methods:  Longitudinal analysis was performed retrospectively on data collected from the
Bogalusa Heart Study cohort (n = 1141; 57% white, 43% black) followed from childhood to
adolescence by repeated surveys between 1973 and 1996. Subjects were categorized into low birth
weight (below the race-specific 10th percentile; n = 123) and control (between race-specific 50–75th
percentile; n = 296) groups.
Results: Low birth weight group vs control group had lower mean HDL cholesterol (p = 0.05) and
higher LDL cholesterol (p = 0.05) during childhood (ages 4–11 years); higher glucose (p = 0.02)
during adolescence. Yearly rates of change from childhood to adolescence in systolic blood
pressure (p = 0.02), LDL cholesterol (p = 0.05), and glucose (p = 0.07) were faster, and body mass
index (p = 0.03) slower among the low birth weight group. In a multivariate analysis, low birth
weight was related independently and adversely to longitudinal trends in systolic blood pressure (p
= 0.004), triglycerides (p = 0.03), and glucose (p = 0.07), regardless of race or gender. These
adverse associations became amplified with age.
Conclusions: Low birth weight is characterized by adverse developmental trends in metabolic and
hemodynamic variables during childhood and adolescence; and thus, it may be an early risk factor
in this regard.
Background
The growth of a fetus in an undernourished intrauterine
environment is considered to result in adaptive fetal pro-
gramming or metabolic imprinting with
Published: 03 November 2004
BMC Pediatrics 2004, 4:22 doi:10.1186/1471-2431-4-22
Received: 27 May 2004
Accepted: 03 November 2004
This article is available from: http://www.biomedcentral.com/1471-2431/4/22
© 2004 Frontini et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
Page 2 of 7
(page number not for citation purposes)
pathophysiologic consequences later in life [1-4]. It is
contended that low birth weight at term (<2500 g), a sur-
rogate for impaired gestational environment, is uncom-
mon in industrialized societies, and deprivations that
existed before the second world war no longer apply to
pregnancies at present [5,6]. In reality, the United States
birth data for year 2002 show a prevalence of 7.8% low
birth weight, with blacks showing almost twice the rate of
whites [7]. Studies world-wide, regardless of socio-eco-
nomic background, have linked low birth weight to
increased risk of insulin resistance, dyslipidemia, hyper-
tension, coronary heart disease, and type 2 diabetes [8-
13], although some studies have found a weak or no asso-
ciations in this regard [5,14-16].
Several studies including our own have examined the
association between low birth weight and selected cardio-
vascular risk factor variables in childhood and adoles-
cence [17-27]. However, information is scant on data
linking low birth weight to longitudinal changes of cardi-
ovascular risk factor variables measured simultaneously
and serially from childhood to adolescence. As part of the
Bogalusa Heart Study, a biracial (black-white) commu-
nity-based investigation of evolution of cardiovascular
risk since childhood [28], the present analysis examines
the relationship between low birth weight and the longi-
tudinal trends of adiposity, blood pressure, lipids and




Between 1973 and 1996, 7 cross-sectional surveys of chil-
dren and adolescents were conducted in the community
(65% white, 35% black) of Bogalusa, LA. This panel
design, based on repeated cross-sectional examinations
performed every 3 to 4 years, resulted in serial observa-
tions required for the longitudinal analysis. For the
present report, two sets of data were merged as described
previously [21]: 1) singleton new born cohort participants
(n = 233) whose weights were measured at birth as part of
the initial examination during 1973–1974; and 2) single-
tons (n = 1213) aged 7–11 years who participated in
1987–1988 cross-sectional survey and whose birth weight
records were obtained from the Office of Vital Statistics in
New Orleans in 1991. Of those with birth weight data (n
= 1436), 1329 subjects participated in 2 to 7 surveys of
children and adolescents. Exclusion of those with missing
data (n = 170), congenital heart disease (n = 11), and dia-
betes (n = 7) resulted in 1141 eligible subjects (57%
white, 47% female).
Low birth weight and control groups were selected from
the eligible cohort, according to birth weight percentile
cut points [29]. Subjects (n = 123) who had birth weight
below the race-specific 10th percentile (whites: <2749 g;
blacks: <2438 g) were categorized as low birth weight
group; those (n = 296) in the upper normal range of 50–
75th percentile (whites: 3402 – 3770 g; blacks: 3133 g –
3487 g) as control group. Birth weights above the 75th per-
centile were not included in the control group because of
the u-shaped associations between birth weight and risk
factors or disease [3,30]. Race-specific percentile, rather
than World Health Organization (WHO) criterion for low
birth weight (<2500 g) was used to define low birth
weight because of black-white differences in birth weight
distribution [31,32].
General examination
Identical protocols were used by trained examiners across
all surveys [33]. Subjects were instructed to fast for 12
hours prior to screening, and compliance was determined
by interview on the morning of examination. Anthropo-
metric and blood pressure measurements were made in
replicate and mean values were used.
Height and weight were measured 2 times; subscapular
skinfold thickness 3 times. Body mass index (BMI) calcu-
lated as weight in kg divided by the square of the height in
meters was used as a measure of overall adiposity; sub-
scapular skinfold for truncal fatness. The reproducibility
in terms of intraclass (intra-observer) correlation coeffi-
cient was greater than 0.99 for weight and height, and
greater than 0.97 for subscapular skinfold.
Blood pressure levels were measured in 6 replicates by 2
randomly assigned nurses on the right arm of subjects in
a relaxed, sitting position. Systolic and diastolic blood
pressures were recorded at the first, fourth, and fifth
Korotkoff phases using mercury sphygmomanometer. For
this analysis fourth phase was used for diastolic blood
pressure because in our experience the fourth phase is
more reliably measured in children and more predictive
of adult hypertension [34].
Laboratory analyses
From 1973 to 1986 cholesterol and triglyceride levels in
serum were measured using chemical procedures on Tech-
nicon Autoanalyzer II (Technician Instrument Corp., Tar-
rytown, NY). Since then these measurements were done
using enzymatic procedures on Abbott VP instrument
(Abbott laboratories, North Chicago, IL). Serum lipopro-
tein cholesterols were analyzed by a combination of
heparin-calcium precipitation and agar-agarose gel elec-
trophoresis procedures [35]. Both chemical and enzy-
matic procedures met the performance requirement of the
Lipid Standardization Program of the Centers for Disease
Control and Prevention, Atlanta, GA. The laboratory has
been monitored for precision and accuracy by the agency's
surveillance program since 1973. For example, the averageBMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
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bias in levels of total cholesterol on CDC control samples
ranged from -0.1 to -1.6 mg/dL between different cross-
sectional surveys, with no consistent pattern over time
within or between surveys. The intraclass correlation coef-
ficients between the blind duplicate (10% random sam-
ple) values ranged from 0.87 to 0.99 for total cholesterol;
0.88 to 0.99 for triglycerides; 0.86 to 0.98 for LDL choles-
terol; and 0.86 to 0.98 for HDL cholesterol.
Plasma immunoreactive insulin levels were measured by
a commercial radioimmunoassay kit (Phadebas, Pharma-
cia Diagnostics, Piscataway, NJ). Plasma glucose was
measured by a glucose oxidase method either using a
Beckman glucose analyzer (Beckman Instruments, Fuller-
ton, CA) or as part of a multichemistry (SMA20) profile.
The intraclass correlation coefficient between blind dupli-
cate values ranged from 0.94 to 0.98 for insulin and 0.86
to 0.98 for glucose. An index of insulin resistance was cal-
culated according to the homeostasis assessment model
formula [36]: HOMA-IR=fasting insulin (µu/mL) × fasting
glucose (mmol/L) ÷ 22.5.
Statistical analyses
For test of significance glucose and insulin were logarith-
mically transformed to approach normality. The average
of multiple measurements for subjects within age groups
4 to 11 and 12 to 18 years corresponding to childhood
and adolescence periods was used to calculate mean levels
of risk variables by birth weight status and age groups.
Mean levels of risk variables within each age group were
compared between low birth weight and control group by
a general linear model, adjusting for age, race, and gender.
The longitudinal rates of change in risk variables was
assessed by the generalized estimation equation (GEE)
method [37] with age as predictor, adjusting for race and
gender. Independent association of low birth weight with
longitudinal trends of risk variables from childhood to
adolescence was assessed by multivariate analysis (GEE).
The model included birth weight (low vs control) and risk
variables as applicable along with age, age2, race and gen-
der and their interaction with birth weight (low vs con-
trol). A backward stepwise method was used to remove
nonsignificant terms.
Results
Mean levels of cardiovascular risk variables during child-
hood (ages 4–11 years) and adolescence (ages 12–18
years) periods are shown in table 1 by birth weight
groups. Of the risk variables adjusted for age, race, and
gender, levels of HDL cholesterol were significantly lower
and LDL cholesterol higher among low birth weight group
vs control group during childhood. During adolescence,
only glucose levels were significantly higher among low
birth weight group vs control group.
Longitudinal rates of change in cardiovascular risk varia-
bles from childhood to adolescence, adjusted for race and
gender, are presented in table 2 by birth weight groups.
The rate of increase in BMI was significantly lower in low
birth weight group compared with control group, while
the rate of increase in subscapular skinfold remained sim-
ilar between the groups. With respect to blood pressure,
the rate of increase in systolic blood pressure was signifi-
cantly higher in low birth weight group than control
group. Of the measures of glucose homeostasis, rate of
increase of glucose was marginally significant in low birth
weight group vs control group. Low birth weight was asso-
ciated with significantly higher rate of increase in LDL
cholesterol; and no significant trends in HDL cholesterol
and triglycerides.
Table 1: Levels (mean ± SD) of risk variables during childhood and adolescence by birth weight. The Bogalusa Heart Study
Variable Childhood (4–11 years) Adolescence (12–18 years)
Low Birth Weight Control Low Birth Weight Control
BMI (kg/m2) 16.7 ± 2.6 17.5 ± 2.9 21.6 ± 5.2 22.7 ± 5.0
Subsc. Skinfold (mm) 8.2 ± 5.1 8.3 ± 6.4 15.9 ± 10.0 16.0 ± 10.7
Syst. BP (mm Hg) 96.4 ± 9.0 98.6 ± 8.1 108.8 ± 9.1 105.2 ± 8.7
Diast. BP (mm Hg) 57.2 ± 10.2 58.7 ± 7.9 66.1 ± 8.0 66.4 ± 7.4
Triglycerides (mg/dL) 62.6 ± 23.2 52.8 ± 20.3 87.1 ± 29.0 83.2 ± 35.3
HDL cholesterol (mg/dL) 44.3 ± 22.6a 54.7 ± 17.4 49.9 ± 12.8 51.2 ± 11.5
LDL cholesterol (mg/dL) 76.0 ± 35.4 a 68.6 ± 37.6 99.5 ± 24.7 98.4 ± 24.3
Glucose (mg/dL) 79.7 ± 8.1 80.9 ± 9.7 85.4 ± 8.2b 81.6 ± 7.4
Insulin (µu/mL) 8.5 ± 5.7 7.4 ± 4.6 14.8 ± 7.5 13.2 ± 8.6
HOMA-IR 1.7 ± 1.2 1.6 ± 1.0 3.0 ± 2.4 2.7 ± 2.0
Difference between groups (adjusted for age, race, and gender), a: p = 0.05; b: p = 0.02
HOMA-IR: homeostasis model assessment index of insulin resistanceBMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
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In a multivariate analysis, low birth weight was retained as
an independent predictor variable for adverse longitudi-
nal trends in systolic blood pressure, triglycerides, and
glucose (marginal) from childhood to adolescence,
regardless of race or gender (table 3). Further, there was a
significant interaction between low birth weight and age
in this regard, denoting that these variables increased to a
greater extent in the low birth weight group than in the
control group as individuals became older. An analysis of
this data set using the WHO criterion for low birth weight
(<2500 g) showed that only 36 subjects were reclassified
as having normal birth weight, and the results were essen-
tially the same (data not shown).
Discussion
Information is sparse at a community level in the U.S.
general population regarding the effects of low birth
weight on the longitudinal trends in C-V risk factor varia-
bles measured serially and concurrently from childhood
to adolescence. The present community-based study dem-
onstrates the adverse effects of low birth weight on the
longitudinal (developmental) trends in systolic blood
pressure, triglycerides, and glucose during childhood and
adolescence, regardless of race or gender. These observa-
tions are in accord with the emerging evidence supporting
the concept of intrauterine imprinting and its
pathophysiologic consequences enunciated by the fetal
origin or thrifty phenotype hypothesis [3].
Many, but not all, previous studies in children and adoles-
cents have found adverse associations between birth
weight and levels of cardiovascular risk factor variables
[16-27]. In this study, the magnitude of differences in
mean levels of cardiovascular risk factor variables between
low birth weight and control groups during childhood
and adolescence periods were small and nonsignificant
Table 2: Rates of change in risk variables from childhood to adolescence by birth weight. The Bogalusa Heart Study
Variable Low Birth Weight Control p-value
BMI (kg/m2/y) 0.60† 0.71 0.03
Subsc. Skinfold (mm/y) 0.91 1.12 0.27
Syst. BP (mmHg/y) 1.70 1.30 0.02
Diast. BP (mm Hg/y) 1.21 1.02 0.26
Triglycerides (mg/dL/y) 2.28 2.92 0.80
HDL cholesterol (mg/dL/y) -0.53 -0.91 0.24
LDL cholesterol (mg/dL/y) 0.80 0.64 0.05
Glucose (mg/dL/y) 0.50 0.11 0.07
Insulin (µu/mL/y) 0.79 0.67 0.70
HOMA-IR 0.18 0.14 0.44
†Regression slope with respect to age in years (y) adjusted for race and gender (generalized equation estimation method).
HOMA-IR: homeostatis model assessment index of insulin resistance.
Table 3: Independent association of low birth weight with longitudinal trends of systolic blood pressure, triglycerides and glucose from 
childhood to adolescence
Independent Variables Retained Syst. BP Triglycerides Glucose
β† p-value β p-value β p-value
Birth Weight (low vs control) 3.84 0.02 48.6 0.08 15.20 0.07
Gender (male vs female) -- -- -- -- 4.31 <0.001
Age 0.39 0.40 12.21 0.01 6.60 <0.001
Age2 0.06 0.002 -0.44 0.04 -0.31 <0.001
Insulin 0.11 0.03 1.16 <0.001 0.22 0.02
B M I 0 . 3 4 < 0 . 0 0 1 - -- -- -- -
Birth weight × age 0.45 0.004 12.71 0.03 0.10 0.07
Birth weight × age2 -- -- 0.55 0.02 2.65 0.10
†GEE regression coefficient. The model included birth weight (low vs control) along with age, age2, race, and gender, and their interaction with birth 
weight; and risk variable as applicable.BMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
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for most of the study variables, except for the adverse lev-
els HDL cholesterol and LDL cholesterol in childhood
and glucose in adolescence among the low birth weight
group. However, in a multivariate analysis of the serial
data, the independent adverse effects of low birth weight
on the longitudinal trends of systolic blood pressure, trig-
lycerides, and glucose were discernable in the study
cohort. Of note, the observed adverse trends associated
with low birth weight vs control group were influenced by
age in that the differences became greater in magnitude as
the children got older. Earlier studies have reported that
the inverse associations between birth weight and levels of
cardiovascular risk factor variables became stronger with
increasing age [26,38]. Whether the potentiating effect of
increasing age on low birth weight – risk variable relation-
ship reflects the interaction between fetal programming
related to intrauterine malnutrition and the increasing
burden with age of unhealthy life-style behaviors includ-
ing overnutrition and sedentary life style is not clear. In
this context, it should be noted that although the rate of
yearly increase in BMI, which also includes muscle mass,
was significantly lower in low birth weight group, the rate
of increase in subscapular skinfold, a measure of truncal
fat, remained similar to that of control group. This sug-
gests a gaining of truncal fat, in relative term, over muscle
mass in the low birth weight group.
Although observational studies like the present one can
not establish causality, several putative mechanisms link
low birth weight to adverse trends in risk factor variables.
It has been suggested that insulin resistance may be one
mechanism by which intrauterine events may program
disease risk [39]. Undernutrition in utero is known to
cause permanent impairment in growth, structure and
function of muscle [39,40], fat [41,42], endocrine pan-
creas [2,43], liver [30], renal nephrons [44,45] and vascu-
lature [46] due to biologic programming, resulting in
insulin resistance/glucose intolerance, hypertension, and
dyslipidemia. Further, it has been suggested that intrauter-
ine programming of the hypothalamic-pituitary-adrenal
axis may be a functional mechanism underlying the link
between low birth weight and above disorders [47],
known as components of insulin resistance or metabolic
syndrome [48].
This study has certain limitations. The lack of information
on the duration of gestation precluded us from adjusting
the birth weight for gestational age, a potential con-
founder. However, earlier studies have found that adverse
effects of low birth weight on cardiovascular risk factor
variables were independent of gestation period
[10,17,49]. Further, it has been pointed out that inclusion
of preterm births could actually underestimate these asso-
ciations [28]. This study also lacks measurements of glu-
cose tolerance and insulin action and secretion used in
etiologic studies. Instead, we used the glucose homeosta-
sis measures that are relatively easily measured and appli-
cable at a population level.
Conclusions
Low birth is characterized by adverse developmental
trends in metabolic and hemodynamic variables during
childhood and adolescence, especially as the children get
older. These observations in conjunction with earlier find-
ings support the view that low birth weight, albeit a crude
marker of prenatal growth and physiological environ-
ment, is a potential early risk factor for the emergence of
metabolic and hemodynamic disorders and related dis-
eases [1,50].
Abbreviations
BMI, body mass index; LDL, low-density lipoprotein;
HDL, high-density lipoprotein
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
MGF participated in study design, data analysis and man-
uscript preparation. SRS and GSB contributed to study
concept and design, data collection, acquisition of fund-
ing and manuscript preparation. JX was involved in meas-
urements of laboratory variables. All authors read and
approved the final manuscript.
Acknowledgements
Supported by NIH grants AG-16592 from the National Institute on Aging; 
HL-38844 from the National Heart, Blood and Lung Institute; and HD-
043820 from the National Institute of child Health and Human 
Development.
The Bogalusa Heart Study is a joint effort of many investigators and staff 
members whose contribution is gratefully acknowledged. We especially 
thank the Bogalusa, LA school system and the participants and their 
parents.
References
1. Barker DJ: Mothers, Babies and Health in Later Life. 2nd edi-
tion. Edinburgh, United Kingdom: Churchill Livingstone; 1998. 
2. Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes
mellitus: the thrifty phenotype hypothesis. Diabetologia 1992,
35:595-601.
3. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LTH, Knowler WC,
Bennet PH: Birth weight and non-insulin dependent diabetes:
thrifty genotype, thrifty phenotype, or surviving small baby
genotype? BMJ 1994, 308:942-945.
4. Waterland RA, Garza C: Potential mechanisms of metabolic
imprinting that lead to chronic disease. Am J Clin Nutr 1999,
69:179-197.
5. Wilkin TJ, Metcalf BS, Murphy MJ, Kirkby J, Jeffery AN, Voss LD: The
relative contributions of birth weight, weight change, and
current weight to insulin resistance in contemporary 5-year
olds. The Early Bird Study. Diabetes 2002, 51:3468-3472.
6. Progress Towards Health for All. Statistics of Member
States. Geneva, World Health Organization; 1994:26-35. BMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
Page 6 of 7
(page number not for citation purposes)
7. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson
ML: Births: final data for 2002. Natl Vital Stat Rep 2003, 52:1043.
8. Barker DJP, Hales CN, Fall CH, Osmond C, Phipps K, Clark PMS:
Type 2 (non-insulin-dependent) diabetes mellitus, hyperten-
sion and hyperlipidemia (Syndrome X): relation to reduced
fetal growth. Diabetologia 1993, 36:62-67.
9. Fall CHD, Stein CE, Kumaran K, Cox V, Osmond C, Barker DJP,
Hales CN: Size at birth, maternal weight, and non-insulin
dependent diabetes in South India.  Diabet Med 1998,
15:220-227.
10. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willet WC, Gillman
MW, Hennekens CH, Speizer FE, Manson JE: Birth weight and the
risk of type 2 diabetes mellitus in adult women. Ann Intern Med
1999, 130:278-284.
11. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP: Birth
weight and adult health outcomes in a bi-ethnic population
in the USA. Diabetologia 1996, 37:624-631.
12. Barker DJP, Osmond C, Winter PD, Margetts B, Simmonds SJ:
Weight in infancy and death from ischemic heart disease.
Lancet 1989, 2:577-580.
13. Leon DA, Lithell HO, Vageno D, Koupilova I, Mohsen R, Berglund L:
Reduced fetal growth rate and increased risk of death from
ischaemic heart disease: cohort study of 15,000 Swedish men
and women born 1915–1929. BMJ 1998, 317:241-244.
14. Falkner B, Hulmann S, Kushner H: Birth weight versus childhood
growth determinants of adult blood pressure.  Hypertension
1998, 31(part 1):145-150.
15. Huxley R, Neil A, Collins R: Unravelling the fetal origins'
hypothesis: is there really an inverse association between
birth weight and subsequent blood pressure?  Lancet 2002,
360:659-665.
16. Williams S, St George IM, Silva PA: Intrauterine growth retarda-
tion and blood pressure at age seven and eighteen.  J Clin
Epidemiol 1992, 45:1257-1263.
17. Uiterwaal CSP, Anthony S, Lanner LJ, Witterman JCM, Trouwborst
AMW, Hofman A, Grobbee DE: Birth weight, growth, and blood
pressure. An annual follow-up study of children aged 4
through 21 years. Hypertension 1997, 30(part 1):267-271.
18. Forrester TE, Willes RJ, Bennett FI, Simeon D, Osmond C, Allen M,
Chung AP, Scott P: Fetal growth and cardiovascular risk factors
in Jamaican school children. BMJ 1996, 312:156-160.
19. Falkner B, Hulman S, Kushner H: Effect of birth weight on blood
pressure and body size in early adolescence. Hypertension 2004,
43:203-207.
20. Whincup PH, Cook DG, Shaper AG: Early influence on blood
pressure: a study of children aged 5–7 years.  BMJ 1989,
299:587-591.
21. Donker GA, Labarthe DR, Harris RB, Selwyn BJ, Wattigney W, Ber-
enson GS: Low birth weight and blood pressure at age 7–11
years in a biracial sample. Am J Epidemiol 1997, 145:387-397.
22. Donker GA, Labarthe DR, Harris RB, Selwyn BJ, Srinivasan SR, Wat-
tigney W, Berenson GS: Low birth weight and serum lipid con-
centrations at age 7–11 years in a biracial sample.  Am J
Epidemiol 1997, 45:398-407.
23. Mzayek F, Sherwin R, Fonseca V, Valdez R, Srinivasan SR, Cruickshank
JK, Berenson GS: Differential association of birth weight with
cardiovascular risk variables in African-Americans and
Whites: The Bogalusa Heart Study.  Ann Epidemiol 2004,
14:258-264.
24. Bardekar A, Yajnik CS, Chittaranjan S, Fall CHD, Bapat S, Pandit AN,
Deshpande V, Bhave S, Kellingray SD, Joglekar C: Insulin resistance
syndrome in 8-year old Indian children: small at birth, big at
8 years, or both? Diabetes 1999, 48:2422-2429.
25. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH,
Knowler WC: Birth weight, type 2 diabetes, and insulin resist-
ance in Pima Indian children and young adults. Diabetes Care
1999, 22:944-950.
26. Li C, Johnson MS, Goran MI: Effects of low birth weight on insu-
lin resistance syndrome in Caucasian and African-American
children. Diabetes Care 2001, 24:2035-2042.
27. Murtaugh MA, Jacobs DR Jr, Moran A, Steinberger J, Sinaiko AR:
Relation of birth weight to fasting insulin, insulin resistance,
and body size in adolescence. Diabetes Care 2003, 26:187-192.
28. The Bogalusa Heart Study 20th Anniversary Symposium. Am
J Med Sci 1995:S1-S138.
29. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA: Early
differential defects of insulin secretion and action in 19-year
old Caucasian men who had low birth weight. Diabetes 2002,
51:1271-1280.
30. Barker DJ, Martyn CN, Osmond C, Wield GA: Abnormal liver
growth in utero and death from coronary heart disease. BMJ
1995, 310:703-704.
31. Frerichs RR, Srinivasan SR, Webber LS, Rieth MC, Berenson GS:
Serum lipids and lipoproteins at birth in a biracial popula-
tion: the Bogalusa Heart Study. Pediatr Res 1978, 12:858-863.
32. Alexander GR, Kogan MD, Himes JH: 1994–1996 U.S. singleton
birth weight percentiles for gestational age by race, Hispanic
origin, and gender. Matern Child Health J 1999, 3:225-231.
33. Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR,
Frank GC, Foster TA, Bland CV: Cardiovascular risk factors in
children. The early natural history of atherosclerosis and
essential hypertension. Oxford: Oxford University Press; 1980. 
34. Elkasabany AM, Urbina EM, Daniels SR, Berenson GS: Prediction of
adult hypertension by K4 and K5 diastolic blood pressure in
children: The Bogalusa Heart Study.  J Pediatr 1998,
132:687-692.
35. Srinivasan SR, Berenson GS: Serum lipoproteins in children and
methods for study. In In: CRC Handbook of Electrophonesis. Lipopro-
tein methodology human studies Volume III. Edited by: Lewis LA. CRC
Press: Boca Raton, FL; 1983:185-203. 
36. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC: Homeostasis model assessment: insulin resistance
and β-cell function from fasting plasma glucose and insulin
concentrations in man. Diabetologia 1985, 28:412-149.
37. Diggle PJ, Liang KY, Zeger SL: Analysis of Longitudinal Data. New
York, NY Oxford University Press; 1994. 
38. Law CM, de Swiet M, Osmond C, Fayers PM, Barker DJ, Cruddas AM,
Fall CH: Initiations of hypertension in utero and its amplifica-
tions throughout life. BMJ 1993, 306:24-27.
39. Phillips DIW: Insulin resistance as a programmed response to
fetal malnutrition. Diabetologia 1996, 39:1119-1122.
40. Taylor DJ, Thompson CH, Kemp GJ, Barnes PRJ, Sanderson A, Radda
GK, Phillips DI: A relationship between impaired fetal growth
and reduced muscle glycolysis reveled by 31P magnetic reso-
nance spectroscopy. Diabetologia 1995, 38:1205-1212.
41. Lapillone A, Braillon P, Chatelain PA, Delmas PD, Salle BD: Body
composition in appropriate and small for gestational age
infants. Acta Paedriatr 1997, 86:196-200.
42. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C: Insulin resist-
ance early in adulthood in subject born with intrauterine
growth retardation. J Clin Endocrinol Metab 2000, 85:1401-1406.
43. Dahri S, Reusens B, Remacle C, Hoet JJ: Nutritional influences on
pancreatic development and potential links with non-insulin-
dependent diabetes. Prac Nutr Soc 1995, 54:345-356.
44. MacKenzie HS, Brenner BM: Fewer nephrons at birth: a missing
link in the etiology of essential hypertension? Am J Kidney Dis
1995, 26:91-98.
45. Hinchliffe SA, Lynch MRJ, Sargent PH, Howard CV, Velzen DV: The
effect of intrauterine growth retardation on the develop-
ment of renal nephrons. Br J Obstet Gynecol 1992, 99:296-301.
46. Leeson CP, Whincup PH, Cook DG, Donald AE, Papacosta O, Lucas
A, Deanfield JE: Flow-mediated dilation in 9- to 11-year-old
children: the influence of intrauterine and childhood factors.
Circulation 1997, 96:2233-2238.
47. Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ,
Walker BR: Elevated plasma cortisol concentrations: a link
between low birth weight and the insulin resistance
syndrome. J Clin Endocrinol Metab 1998, 83:757-760.
48. Reaven GM: Role of insulin resistance in human disease. Diabe-
tes 1988, 37:1595-1607.
49. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker
D: The fetal growth and childhood growth of persons who
develop type 2 diabetes. Ann Intern Med 2000, 133:176-182.
50. Eriksson JG: Growth and coronary heart disease in adult life.
Cardiovasc Res Rev 2002, 23:557-0560.
Pre-publication history
The pre-publication history for this paper can be accessed
here:Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2004, 4:22 http://www.biomedcentral.com/1471-2431/4/22
Page 7 of 7
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2431/4/22/prepub